Dr. Matthew Recko, MD

Dr. Recko practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Recko's NPI, 1598080558, was assigned on April 2, 2010. Dr. Recko graduated from Texas A&M College of Medicine - Bryan in 2010. Dr. Recko holds Texas license P6708.

Dr. Recko's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Recko's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Recko is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Baylor Scott & White Temple Roney Bone and Joint Institute, Temple.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Recko practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Recko's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Recko is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Recko's licenses on file in 2 states: Texas and Missouri.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, eyelid inflammation, glaucoma surgery, hereditary corneal conditions and inflammation of iris among the conditions Dr. Recko treats.

CMS data shows 199 Medicare services from Dr. Recko across 5 procedure codes in 2024, for 159 Medicare patients. Medicare paid $30,185 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 159 Medicare patients who saw Dr. Recko in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Recko's median patient age at 10, with 53% women.

In 2024, Dr. Recko wrote 61 Medicare Part D claims for 35 patients. 79% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $159 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

Dr. Recko accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 47 procedures of cataract surgery by Dr. Recko, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Recko, published from 2020 to 2024. 2022 was the busiest year, with 2. Dr. Recko has published most often in Proc (Bayl Univ Med Cent). Dr. Recko's most frequent co-authors are Maxwell Su, MD, Wesley Matthew Gillette, MD and Matthew Nickell, MD.

CMS Open Payments shows 10 general payments to Dr. Recko from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $223.

Dr. Recko graduated from Texas A&M College of Medicine - Bryan in 2010.

Dr. Recko is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.